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CTLs are known to kill their targets by a contact-dependent mechanism (see
references 1 and 2 for review). The CTL binds to its target presumably through
interaction of the TCR with class I antigens on the target cell surface, perhaps
stabilized by subsidiary interactions involving lymphocyte function-associated
antigen(LFA-1)' andLyt-2 (3, 4). Afterconjugation, the CTLdelivers effectively
a lethal hit, the nature of which has been the subject of intensive research in
several laboratories (see references 1, 2, and 5-8 for review). According to one
model, CTL may synthesize, store, and secrete a pore-forming protein (PFP,
perforin or cytolysin) that inserts into the target membrane in a fashion at least
operationally similar to the complement system (6-8).
After a CTL has damaged its target cell, it is known that the same CTL can
recycle to lyse new targets (9, 10). Throughout the expression of this repetitive
lytic activity, the CTL spares itself from lysis. This observation suggests a
mechanism by which a CTL may protect itself from inflicting self-injury. How-
ever, experiments first reported by Golstein (11), and subsequently confirmed
by other laboratories (12-15), have shown that under certain circumstances
CTLs are lysed by other CTLs, implying that CTLs must themselves be sensitive
to whatever mechanism it is that they use to kill other targets. Ifthis is true, then
it is difficult to imagine how CTLs would escape being killed by any granule
polypeptide they secrete into the intercellular spaces between the effector and
target cells. Here, we report that cloned CTLs are in fact highly resistant to lysis
mediated by primary and cloned CTLs and by isolated cytotoxic CTL granules.
These experiments provide the basis for a protection mechanism by which CTLs
may avoid self-inflicted destruction during the cytolytic reaction.
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'Abbreviations used in this paper:
￿
LAK, lymphokine-activated killer; LDCC, lectin-dependent,
cell-mediatedcytotoxicity;LFA, lymphocyte function-associated antigen; PFP, pore-formingprotein;
PK, promiscuous killer; TCGF,Tcell growth factor.
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Materials and Methods
Animals.
￿
6-8-wk-old CBA/J and C57BL/6 mice were purchased from The Jackson
Laboratory, Bar Harbor, ME. 6-8-wk-old CBA/cum mice were purchased from Cumber-
land View Farms, Clinton, TN. C57BL/6 and DBA/2 retired breeder mice were pur-
chased from Simonsen Laboratories, Inc., Gilroy, CA. BALB.B mice were bred and
maintained in our breeding facility.
Preparation of TCell Growth Factor (TCGF).
￿
IL-2 producing EL-4 cells were grown to
adensityof 10 cells/ml in DME, supplemented with 0.55 MM L-arginine HCL, 0.27 mM
L-asparagine, 1.47 MM L-glutamine, 2 g/L NaHCO3, 5 x 10-5 M 2-ME, antibiotics, and
5% FCS (medium referred as supplemented DME). Thecellswere cultured in thepresence
of PMA at a final concentration of 10 ng/ml. After 40 h, the cell free supernatant was
collected, passed through a 0.22-,um filter, and stored at -20°C. Alternatively, TCGF
wasprepared from rat spleen cell cultures stimulated for 40 h in thepresence of 10 jug/ml
Con A (Pharmacia Fine Chemicals, Uppsala, Sweden) in RPMI with 2% FCS. The
supernatant was collected and stored at -20°C.
Cell Lines.
￿
Clones AB.1 andAB.2 were derivedin our laboratories by limiting dilution
from a line that originally startedas a BALB/c anti-C57BL/6 (H-2aanti-H-26) MLC. AB.1
and AB.2 were selected fortheirability to specifically lyse EL-4 target cells, andtheclones
were expanded into 2-ml flat-bottomed wells (Costar, Cambridge, MA) on a feeder layer
of 6.5 x 106 irradiated cells per each 2-ml well. The clones are maintained in 2-ml wells
with weekly stimulation with 6.5 x 106 irradiated feeder cells in supplemented DME
containing 5% EL-4-conditioned medium as a source of TCGF. On the third day after
stimulation, the cultures were split 1:3 and given fresh medium and TCGF (without
stimulating cells). Clones KB1.24 and KB1.33 were derived in our laboratory in the same
fashion as AB.1 and AB.2, except from a CBA anti-C57BL/6 (k anti-b) MLC.
Clone 83 .4 wasderived from a C57BL/6anti-DBA/2 MLC line kindly provided by Dr.
Michael Bevan (Scripps Clinic and Research Foundation, La Jolla, CA), and cloned and
subclonedby limiting dilution in our laboratory. It was maintained by weekly stimulation
with irradiated DBA/2 splenocytes in RPMI 1640 supplemented with 5% FCS and 5%
rat spleen cell Con A supernatant as a source of TCGF. 105 83 .4 cells were restimulated
with 5 x 106 DBA/2 spleen cells in 2-ml flat-bottomed wells (Costar). The cells were
usually split 1:2 on day 3 with fresh medium and TCGF, but without addition of fresh
stimulator cells.
Clone B3.3.1 was also provided by Dr. Michael Bevan. It was derived in his laboratory
by limiting dilution from a C57BL/6 anti-BALB.B MLC-generated line. It is maintained
in ourlaboratory exactlyas describedaboveforclone 83 .4,except that irradiated BALB.B
spleen cells are used for stimulation.
Clone L3 (C57BL/6 anti-DBA/2; b anti-d) was obtained from Dr. Andrew Glasebrook
(Eli Lilly Research Labs, La Jolla, CA); clone OE-4 (C57BL/6 anti-BALB/c; b anti-d) was
a gift of Dr. Osami Kanegawa (Eli Lilly Research Labs).
The C57BL/6 T cell leukemia EL-4, and the DBA/2 mastocytoma P815, are carried
as ascites tumors by weekly injections of 2 x 106 washed cells into the peritoneal cavities
of syngeneic hosts.
CTL R8 cells, obtained originally from Dr. Michael A. Palladino, Genentech, Inc., So.
San Francisco, CA, have been shown to react to a unique determinant on Rldl cells (16).
They are maintained in aMEM supplemented with 1 mM L-glutamine, nonessential amino
acids, 15% Con A/PMA-stimulated rat spleen cell supernatant, and 10% FCS. Thesecells
were used as asource of cytotoxic granules.
The H-2" lymphoma R1 .1 (17), obtained from American Type Culture Collection
(Rockville, MD), and the mastocytoma P815 cells are maintained in vitro in MEM/FCS.
The EL-4 T cells are maintained by weekly passages in C57BL/6 mice.
MLCs and Promiscuous Killer (PK) Cells.
￿
For MLCs, spleens of 6-8-wk-old mice to be
used as the responding cell population were teased and passed through a stainless steel
screen into sterile PBS. The cells were treated with 0.85% NH,C1 at room temperature
for 4 min to remove erythrocytes, washed twice in cold PBS, and resuspended in
supplemented DME. Retired breeder mice were used as a source of stimulating cells;1072
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spleen cells were prepared asjust described but were irradiated with 2,500 rad from a 60
kV x-ray source. After washing, the responding cells were mixed with the stimulators at
a ratio of 3 :1 . The MLCs were cultured for 5-6 d in DME with 5% FCS at a final
concentration of 2 .5 X 106/ml in 25-cm2 tissue culture flasks (Costar).
PK cells were generated by incubating C57BL/6 naive spleen cells for 5 d in DME
supplemented with 5% FCS and 15% EL-4-conditioned medium. Promiscuity was estab-
lished by the ability to lyse self target cells in the absence of lectin. A second source of
nonspecific killer cells was generated from cloned CTL by preincubation of the CTL with
10-7 M PMA and 4 X 10-6 M ionomycin for 30 min at 37°C. The cells were washed
three times with PBS before use in
5'Cr-release assays.
Preparation of CTL R8 Granules.
￿
CTL R8 cells were grown in TCGF-containing
medium in large Petri dishes, and were collected after reaching confluence. 2-3 X 10i
cells were washed three times with PBS to remove residual serum, and then disrupted by
nitrogen cavitation, as previously described (18). Granules were prepared by centrifuga-
tion through Percoll gradients, essentially as reported (18). Granule-enriched fractions
were pooled and the Percoll was removed by sedimentation at 180,000 g for 2 h in an
SW41 rotor (Beckman Instruments, Inc., Fullerton, CA) at 4°C. Isolated granules were
extracted with high phosphate buffer as described, and soluble granule proteins were
obtained by sedimentation of granule membranes by high-speedcentrifugation (18). The
final concentration of granules was thereafter adjusted with extraction buffer so that 1 /I
of extract was equivalent to granules isolated from 106 cells. The granule extract was
stored at -20 °C and thawed immediately before use.
Serological Detection of Class I Molecules.
￿
Class I antigen density on the surface of
various cells was determined by means of their ability to absorb cytotoxic activity from a
standard aliquot ofdirectly cytotoxic anti-class I mAb. Varying numbers of test cells were
pelleted and resuspended directly in the standard aliquot of anti-class I mAb, and
incubated 30 min on ice. The cells were repelleted, and a portion of the overlying antibody
was tested in a precalibrated complement-dependent "Cr-release assay. Alternatively, the
density of class I antigens was determined by using a cellular ELISA, essentially as
described (19).
Cytotoxicity Assays.
￿
Appropriate target cells were suspended in 0.3 ml FBS containing
0 .1 mCi Na25 'CrO4 for 45 min at 37°C with occasional mixing. Target cells were washed
three times with cold PBS and stored on ice until use. Effector cells recovered from
culture were washed twice in cold PBS, resuspended in culture medium, and serially
diluted to give the desired effector/target cell ratios upon mixture with 104 target cells in
96-v-well plates in a total volume of 0.2 ml/well. The plates were centrifuged at 300-500
g for 5 min before incubation for 3-4 h in a C02 incubator.
After incubation, the microtiter plates were centrifuged at 1,000 g, and 0.1 ml of the
sample supernates were counted in a gamma counter (Gamma 5500; Beckman Instru-
ments, Inc.). Cytotoxicity was calculated according to the formula: percent cytotoxicity =
100 X [(cpm experimental release) - (cpm spontaneous release)]/[(total cpm) - (cpm
spontaneous release)].
In experiments using soluble granuleproteins as the cytotoxic effector reagent, specified
amounts of the granule extract were plated out in 96-well plates kept on ice. "Cr-labeled
targets were added to a final concentration of 104 cells/200 ul/well in quadruplicate.
Serum-free medium was used to prevent inactivation of granule cytotoxicity by serum.
The plates were incubated at 37°C for 3 h and "Cr released was assayed as before. The
release associated with incubation of targets with extraction buffer alone was subtracted
from each point.
Conjugation Assays.
￿
Target cells were washed and incubated in PBS containing 0.1
mg/ml FITC. Effector and target cells were mixed together either at 10:1 (primary
effector cells) or 1 :1 (cloned CTL effector cells), and centrifuged at 300 g for 5 min.
Pelleted cell mixtures with cloned CTL effector cells were resuspended immediately after
centrifugation to reduce extensive cell clumping. In both cases, resuspension was accom-
plished with a fixed number of strokes through a plastic disposable pipette tip. The cell
mixture was analyzed by direct visualization through a fluorescence microscope. A totalBLAKELY ET AL.
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TABLE I
Cloned CTLs Are Highly Resistant to Direct CTL-mediated Lysis
Effector cell
￿
Target cell
Results
Net percent "Cr release at E/T ratio of:
20:1 10:1 5:1 2.5:1 1.2:1 0.6:1
83.4 (b anti-d)
￿
P815 (H-2d)
￿
89
￿
81
￿
77
￿
69
￿
62
￿
41
EL-4 (H-2b
)
￿
-1
￿
-3
￿
0
￿
0
￿
2
￿
1
AB.2 (d anti-b)
￿
2
￿
3
￿
-1
￿
0
￿
-2
￿
-2
AB. 1 (d anti-b)
￿
2
￿
-1
￿
-2
￿
1
￿
ND
￿
ND
AB.2 (d anti-b)
￿
EL-4 (H-2b)
￿
93
￿
96
￿
91
￿
87
￿
83
￿
72
P815 (H-2d)
￿
0
￿
0
￿
-3
￿
-3
￿
-1
￿
-2
83.4 (b anti-d)
￿
-1
￿
0
￿
0
￿
0
￿
3
￿
-1
B3.3.1 (b anti-BALB.B)
￿
0
￿
3
￿
-5
￿
-1
￿
2
￿
1
OE4 (b anti-d)
￿
-2
￿
0
￿
-2
￿
-1
￿
ND
￿
ND
L3 (b anti-d)
￿
4
￿
3
￿
4
￿
4
￿
ND
￿
ND
KB1 .24 (k anti-b)
￿
EL-4 (H-2b)
￿
70
￿
72
￿
63
￿
54
￿
40
￿
41
P815 (H-2d)
￿
2
￿
3
￿
0
￿
-1
￿
ND
￿
ND
A20.2J (H-2d)
￿
2
￿
-1
￿
-1
￿
-2
￿
ND
￿
ND
83.4 (b anti-d)
￿
-3
￿
0
￿
-11
￿
-4
￿
ND
￿
ND
L3 (b anti-d)
￿
2
￿
2
￿
1
￿
0
￿
ND
￿
ND
H7.1 (b anti-BALB.B)
￿
ND
￿
3
￿
1
￿
0
￿
-1
￿
ND
CTL clones 83.4 (H-2b anti-H-2d), AB.2 (H-2d anti-H-2), and KB 1 .24 (H-2' anti-H-2) were used as
effector cells in 3-h -"Cr release assays against the indicated target cells. Spontaneous release values
for P815 and EL-4 targets were <10% ; for AB.2, B3.3.1, 83.4, OE4, H7.1, and L3, 17, 27, 29, 20,
27 and 30%, respectively.
of 300 target cells was counted, and the percentage having one or more effector cells
bound was recorded.
Pretreatment of Target Cells with Lectin for LDCC Assays.
￿
P815 mastocytoma, EL-4
leukemia tumor, and CTL clones were used as target cells in lectin-dependent cellular
cytotoxicity (LDCC) assays. Target cells first labeled with "Cr as described above, were
washed three times with PBS, and then resuspended in RPMI containing 5% FCS at a cell
density of 5-7 x 106 cells/ml. To this, 13 ug/ml Con A was added, and allowed to
incubate 30 min at 37°C. The cells were washed twice with RPMI (with 5% FCS),
resuspended to the desired concentration and used in the "Cr-release assay described
above.
CTL Clones are Highly Resistant to Direct CTL-mediated Lysis.
￿
Table I shows
the results of several experiments in which we used a variety of cells, including
several cloned CTLs, as targets for direct, antigen-specific killing by various
cloned CTL effector cells. In every case, the effector cells lysed the normal
specific targets very well, and the "normal" nonspecific target cells not at all, as
expected, since effector clones were initially selected on the basis of this antigen-
specific lytic capability (see Materials and Methods). However, in parallel exper-
iments, we were completely unable to lyse any cloned CTL as a target cell, even
though the target CTLs used displayed the same class I antigens as the other
normal lysis-sensitive targets. Lack of lysis between cloned CTLs was observed
whether recognition was bidirectional or unidirectional (Table I).
We also tested the sensitivity of cloned CTLs (as targets) to lysis by primary1074
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FIGURE 1.
￿
Cloned CTLarepoorly sus-
ceptible to lysis by primary effector
CTL. Primary CTLs were generated in
MLCs as described in Materials and
Methods. CBA anti-DBA/2 (A) or CBA
anti-C57BL/6 (B) CTLs were harvested
at 5 d andassayed against the following
target cells. (A)P815; (O) EL4; (p)AB.2;
(A)83.4; (9)B3'.31. Assays were for 3 h
at the indicated E/T ratios.
CTLs generated in MLC. The MLC cultures were harvested on day 5 or 6, and
tested against the specific target, a third party (nonspecific) target, and a CTL
clone syngeneic to the specific target. The results are shown in Fig. 1 . The two
experiments shown are representative of the maximal (A) and minimal (B) levels
of lysis of cloned CTL target cells we have seen in 20 such experiments. Taking
the number of effector cells required to give a comparable level of lysis of
different targets as a measure of relative target cell sensitivity, we find that
cloned CTLs are on the average between 10 and 20 times more resistant to
killing by primary CTLs compared with target cells normally used to measure
cytolysis. In most cases, the level of killing of a cloned CTL target for which the
MLC-generated effectors are specific is about the same as that displayed toward
a third-party target cell. This pattern of response is true for primary CTL
effectors generated either in MLCs or by in vivo immunization (datanot shown).
Cloned T Cells Display as much Class I Antigen as Other Target Cells.
￿
Since
direct CTL-mediated lysis is specific for and absolutely dependent upon the
presence of class I MHC antigens, it was important to show that these antigens
are present in normal quantities on our cloned T cell targets. This was accom-
plished by comparing the ability of cloned T cells and normal (lysis-susceptible)
target cells to absorb class I-specific cytolytic antibodies. Sample results are
shown in Fig. 2. The CTL clones AB.2 and 83 .4 show the same levels of anti-
class I antibody-absorbing capability as the respective H-2 syngeneic target cells
P815 and EL-4. Similar results were found for all our CTL clones and other
normal target cells using both the antibody absorption technique and an ELISA
assay for cell surface antigens (data not shown). As shown in Fig. 3, the low level
of lysisof cloned CTL target cells mediated by primary (MLC-generated) effector
cells can be effectively blocked by target cell class I antibodies. We therefore
conclude that the low level of antigen-specific lysis observed is carried out by
CTLs and not by NK or PK cells.
Although cloned CTLs display normal levels of class I MHC antigens, it is still
possible that other CTLs are not able to bind properly to them. Analyses were
therefore carried out to verify conjugate formation using both cloned and
primary CTLs as effector cells, and cloned CTLs as targets. Analysis of thew
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FIGURE 2.
￿
Cloned CTL display
as much serologically detectable
class I antigen as lysis-susceptible
target cells. Cloned CTLs were
comparedwith H-2-identicallysis-
susceptible target cells for their
ability to absorb class I-specific
cytotoxic mAbs as described in
Materials and Methods section.
(A) The H-2d CTL clone AB.2
(p) compared with the H-2d tar-
getL10.A (0). (B)The H-2b CTL
cloned 81.4 (A) compared with
theH-2b target EL-4 (A).
FIGURE 3.
￿
Low levels of lysis of cloned CTL by primary
effector cells is classI-dependent. Primary CTLs generated
in a CBAanti-C57BL/6 primaryMLC(k anti-b) were tested
against EL-4 target cells ([I, IN) or the bad CTL clone 83 .4
(A, A). Assays were carried out in the presence of normal
serum (open symbols), or an antiserum specific for H-26 class
I proteins (closed symbols).
binding of both primary and cloned CTL effectors to cloned CTL targets was
difficult, due to excessive nonspecific aggregation particularly in clone/anticlone
combinations. The clumps formed between cloned CTLs and their specific
targets obviously contained both effector cells and fluoresceinated targets, but
precise quantitation was difficult. Because of technical problems in conjugate
scoring, it was not possible to reach a definitive conclusion about specificity of
binding of either primary or cloned CTL effectors to cloned T cell targets.
Sensitivity of Cloned CTL to Lysis in LDCC.
￿
To further assess the extent of
resistance displayed by CTLs to lysis by other CTLs, we tested the ability of
cloned CTLs to kill cloned T cell targets in LDCC. Lectins are known to activate
CTLs to lyse targets to which they adhere, irrespective of the target specificity.
Representative results of such experiments are shown in Table 11. The CTL
clone 83 .4 kills the syngeneic target cell EL-4 (H-2b) very efficiently if the latter
is treated first with Con A . However, when tested against five different CTL
clones, 83 .4 was unable to kill any of them, whether they were treated with lectin1076
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TABLE II
Cloned CTLs Are NotLysed in LDCC
Target cells were assayed for lysis directly, or after pulsing with the lectin Con A as described in
MaterialsandMethods. Assay time was 3 h;values shown areaverages of triplicate samples corrected
for spontaneous release.
or not. Identical results were obtained (a) with all CTL clones as effectors or
targets; (b) whether the lectin was added free in the assay or precoated onto the
target cell; (c) with both PHA and Con A as the mediating lectin. We also tested
the ability ofprimary CTLs to lyse normal and cloned CTL target cells in LDCC.
A sample ofthese results is also shown in Table II. MLC-generated effector cells
lysed third-party targets very well in the presence of Con A, but were unable to
lyse cloned CTL targets effectively. We found in every case that the relative
sensitivity of cloned CTLs to lysis in LDCC is about the same as their relative
sensitivity to lysis in direct CTL killing; e.g., between 5 and 10% that ofnormal
target cells.
Susceptibility of Cloned CTLs to Lysis by PK Cells.
￿
Several laboratories have
described the generation ofcytotoxic nonspecific effector cellsfrom lymphocytes
and/or CTL lines in the presence of high levels of TCGF or IL-2, but in the
absence of antigen or mitogen (20-25). They are distinguished from normal,
allospecific CTLs in that they kill target cells in a class I-independent fashion
(21-23). They maybe distinguishedfrom NKcellsin that theykill untransformed
selftarget cells as well as transformed selfand nonselfcells (23).
The susceptibility of cloned CTLs to lysis by PK cells generated from naive
C57BL/6 spleen cells is shown in Fig. 4. Both the allogeneic target P815 and the
syngeneic target EL-4 were killed effectively by TCGF-generated promiscuous
C57BL/6 killer cells. However, the cloned CTL targets AB.2 and 83.4, which
are H-2 identical to P815 and EL-4, respectively, were only poorly killed by
Effector cell Target cell Con A
Netpercent "Cr
20:1 10:1
release
5:1
at E/T
2.5:1
ratio of:
1.2:1
83.4 (b anti-d) EL4 (H-26) - 4.0 2.2 1.9 3.3 0.6
+ 66.2 73.1 72.8 69.6 60.4
AB.2 (H-2d) - 0.3 1.6 3.4 -1 .2 2.2
+ 1.4 1.4 0.2 4.1 1.6
83.4 (H-26) - 2.1 2.7 1.6 0 0.2
+ 0.8 0.4 2.1 2.0 2.4
42 (H-2k) - -0.2 -3.2 -3.1 -3 .0 ND
+ 2.8 -3.3 2.5 -1 .6 ND
OE4 (H-26) - -3.7 -4.6 -2.5 -3.4 ND
+ -0.5 -1 .5 -1 .6 -1 .5 ND
KB1.24(H-2k) - 2.7 6.3 2.2 1.8 2.4
+ 0.9 1.1 0.6 4.2 0.1
CBA anti-B6 primary P815 (H-2d) - 8.3 4.2 4.6 0.2 0.4
CTL (k anti-b)
+ 61 .8 60.6 52.3 31 .2 8.6
AB.2 (H-2d) - 10.7 6.6 3.0 2.8 2.9
+ 9.0 8.6 13.1 1.9. 4.8
EL-4 (H-26) - 59.6 51 .7 42.8 29.4 13 .0
+ 50.2 39.3 46.1 28.1 19.550
w 40
a
w J
W 30
U
Z 20
w
U
w
a 10
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FIGURE 4.
￿
Cloned CTLarepoorly lysedby PK cells. C57BL/6
spleen cellswere incubated for 6 d with DME, 5% FCS, supple-
mented with 15% TCGF generatedfrom EL4cells (see Materials
and Methods). The cells were washed and incubated for 3 h
with "Cr-labeled target cellsin theabsenceofexogenousTCGF.
(O) EL4; (A) P815; (0) 83 .4; (A) AB.2.
C57BL/6 PK cells. In our hands, cloned CTLs are even less susceptible to lysis
by PK cells than they are to direct CTL killing or LDCC, using MLC-generated
effector cells.
PMA- and ionomycin-induced Cloned CTLs Kill Normal Target Cells but not
Cloned CTL Target Cells. . Using the method of Russell (26) to induce promis-
cuous killing in cloned CTLs, we tested PMA- and ionomycin-induced CTL
clones against various target cells in a "Cr-release assay. As shown in Table III,
CTL clone 83.4 (b anti-d) lyses its specific target P815 very well, but does not
normally lyse the syngeneic target cell EL-4 or the allogeneic (H-2k) target R1 .1 .
However, after a 30-min exposure to PMA and ionomycin, 83.4 cells were very
effective in lysing both of these target cells. On the other hand, PMA/ionomycin-
induced 83 .4 could not kill the H-2b CTL clone AB.2. This pattern of reactivity
is exactly the same as that seen for direct killing of target cells by untreated
cloned CTL effector cells: normal targets are lysed, but cloned CTL targets are
not. This conclusion was supported with results obtained with all possible com-
binations of cloned CTLs (as effectors and targets) described in this paper.
CTL Clones are Resistant to Lysis by Granule Proteins.
￿
Recent studies in several
laboratories have suggested that cloned CTLs and NK cells contain cytoplasmic
granules/PFP that are lytic to a variety of tumor targets (reviewed in references
6-8). We next determined whether the CTL clones studied here could also be
resistant to the contents of cytotoxic granules. As shown in Fig. 5, cloned CTLs
when used as targets are highly resistant to lysis by granule proteins. CTLs were
either absolutely refractory to lysis (R8, syngeneic to the source of granules) or
weakly susceptible (AB.2, 83 .4, and L3), while non-CTL targets (YAC-1, EL-4,
P815, and RL1) were highly susceptible to granule-mediated lysis. These data
indicate that cloned CTLs resist cytolysis not only at the intact effector cell level
but also when soluble effector proteins are used.
Sensitivity ofCTL Clones to Complement.
￿
The sensitivity of several of our CTL
clones to lysis by complement is shown in Fig. 6 . The cells were first sensitized
with an IgM anti-Thy-1 antibody, and then titrated with guinea pig complement.
In several such experiments, we were unable to detect any difference in sensitivity
to complement-mediated lysis between any of our CTL clones and target cells
normally used to assay cytotoxicity.1078
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TABLE III
PMA/lonomycin-inducedCloned CTLs Lyse Third-party Normal Target Cells, but not Third-
party Cloned CTL Target Cells
CTLclones 83.4 (b anti-d) and KB1.24 (d anti-b) were used as effector cells either directly or after
30 min incubation with PMA (10' M) plus ionomycin (4 X 10-6) at 37°C. Assays were carried out
for3 hat 37°C. The "Cr-release values at the E/Tratios shownarethe average oftriplicate samples,
corrected for spontaneous release.
0 T---9----
2 5 10 15 20
R8 Granule Extract Oil)
Effector cell Treatment Target cell
Netpercent
10:1
"Cr
5:1
release at E/T
2.5:1
ratio of:
1.2:1
83.4 None P815 64.2 66.1 63 .0 42.4
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KB1.24 PMA/iono P815 17 .4 9.2 4.1 3.0
EL-4 64.2 67.2 52.8 41 .7
A20.2J 39.7 20.1 9.8 3.9
83.4 0 0 0 0
AB. 1 2.8 0 0 0
AB.2 0 0 0 0
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60 FIGURE 5. Susceptibility of cloned CTLs and othertargets
to granule-mediated lysis. "Cr-labeled targets were incu-
U bated with granule extracts in a 3-h cytotoxicity assay, as
describedin MaterialsandMethods. Targetswere Yac-1 (O),
-E 40
d EL-4 (0), P815 (X), R1 .1 (A), and CTLs AB.2 (A), 83.4
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FIGURE 6. Sensitivity of cloned CTLs to comple-
ment-mediated lysis. The standard CTL target cell
EL-4 (*) was tested for sensitivity to complement lysis,
along with the following CTL clones: (-A-) L3;
(--*-) ABA ; (--f--) AB.2; (--~--) 83.4;
KB1 .24. After labeling with "Cr, the target cells were
incubated 30 min on ice with an IgM mAb specific
for Thy-1 . The cells were washed in PBS, and then
incubated 60 min at 37°C with varying dilutions of
guinea pig complement, after which "'Cr release was
measured.
Discussion
In direct, class I antigen-specific cytolysis, we find cloned CTLs used as target
cells to be completely refractory to lysis by other cloned CTLs at E/T ratios and
for assay periods sufficient for complete destruction of lysis-susceptible target
cells normally used to measure cytotoxicity. We have tested II CTL clones
generated in our and other laboratories, and have found no exception to this
rule. Cloned CTL targets are also completely resistant to lysis by cloned CTL
effector cells in both Con A- and PHA-mediated LDCC, and by cloned CTL
induced to kill in a promiscuous fashion by PMA.
Unlike cloned CTLs as effectors, we find that primary CTLs are capable of
lysing cloned CTL targets, although only to a low degree. With primary CTL
effectors, we find that on average cloned CTL targets are 5% or less as sensitive
to lysis as are susceptible target cells, that is, it requires on average at least 20
times more effector cells to achieve comparable levels of lysis of cloned CTL
targets, compared to susceptible targets. Inasmuch as the limited lysis of cloned
CTL by primary CTL pul-.Rations that we do observe is class I dependent (Fig.
3), we conclude that the lytic activity is indeed expressed by CTL, and not by
other effector cells such as NK cells. We find the same low degree of sensitivity
to lysis in LDCC, and in promiscuous killingby TCGF-induced spleen cells. Why
cloned CTL targets should be absolutely refractory to lysis by cloned CTL
effectors, yet slightly sensitive to lysis by primary CTLs, is unclear. Cloned CTLs
are extremely potent effectors toward normal target cells, and may be presumed
at least potentially capable ofkilling cloned CTL target cells.
Luciani et al. (27) have recently reported that a given CTL clone is refractory
to lysis by itself in LDCC, but is not refractory to lysis in LDCC by unrelated
CTL clones. While we also find that cloned CTLs do not lyse themselves in
LDCC (Table II), we find in every case we have examined, using either Con A
or PHA, that cloned CTLs are completely resistant to LDCC by all CTL clones.
At present, we cannot explain the differences in our results.
Several laboratories (6-8) have demonstrated that cytotoxic T cell lines main-
tained in long-term, IL-2-driven culture in vitro possess cytotoxic granules, the
contents of which are highly toxic for a wide range of target cells. A lytic PFP
has recently been partially enriched from these granules (18, 19, 28, 29) that1080
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appears to share structural/functional/immunological homologies with the ter-
minal components ofthe membrane attack complex ofcomplement (30-33). We
thus tested our CTL clones for sensitivity to cytotoxic granules. We found that
cloned CTLs but not other non-CTL targets are highly resistant to lysis by
granules, reflecting closely the extraordinary resistance of cloned CTLs to lysis
by other CTLs. This would be consistent with, although it does not prove, a role
for cytotoxic granules in target cell killing by cloned CTLs. The resistance of
cloned CTLs to the granule/PFP-mediated cytolytic pathway is consistent with a
protective mechanism that would spare CTLs from lysis by their own granule
contents during the cytolytic reaction. The possibility that a membrane polypep-
tide ofCTLs could play this protective role, by complexing rapidly with PFP in
the plane of the bilayer, thereby avoiding its further aggregation and lytic
transmembrane pore formation, is currently being assessed in our laboratories.
A similar protective membrane polypeptide (termed C8-binding protein or
homologous restriction factor) has already been described for the complement
system that presumably avoids channel formation at the C8/C9 stage (34, 35).
However, this polypeptide only seems to protect erythrocyte targets against
homologous complement. Thus, the finding that cloned CTLs are susceptible to
lysis by heterologous complement does not rule out that the resistance mecha-
nisms/polypeptides that protect cells from CTL- and complement-mediated
killing may be similar. Experiments are presently being carried out in our
laboratories to address this issue.
Since primary CTLs are able to kill cloned CTLs to some extent, it is possible
that primary CTLs and long-term, IL-2-driven CTL clones kill target cells
through at least partially different mechanisms. Indeed, in preliminary experi-
ments, we have not succeeded in staining granules of murine primary effector
spleen cells with antiserum derived against isolated PFP (our unpublished obser-
vations). Two other groups have also recently failed to demonstrate a role for
cytotoxic granules and their contents in killing by primary CTL (36, 37).
While this manuscript was in preparation, Kranz and Eisen (38) reported on
similar findings ofresistance of several CTL clones to lysis by a clone of CTL.
Unlike our use here ofvarious effectorsand targets in different combinations of
antigen specificity, these authors circumvented variations in target recognition
by attaching to all the targets a monoclonal antibody to the antigen-specific
receptor ofa cloned CTL cell line (clone 2C) and using the 2C cell line as the
only effector cell type. Here we have demonstrated that cloned CTLs are not
only resistant to lysis by whole effector CTLs butalso to lysis bygranule proteins.
It remains to be seen whether the resistance of cloned CTLs to killing is also a
property of primary cytotoxic effector cells. Although the resistance to lysis
exhibited by cloned CTLs may be related to their long-term culture in the
presence of high levels of IL-2, this type of resistance may be physiologically
relevant. Prolonged exposure to IL-2 causes a number of changes in CTL,
including conversion to a broad specificity, promiscuous lytic activity (20-25).
This would in effect recruit any CTL, or potential CTL, in the vicinity of a
stimulus eliciting high IL-2 production (e.g., a massive viral infection, a tumor
focus, etc.), to begin displaying immediate and vigorous lytic activity. It is even
possible, perhaps likely, that the utilization ofa lytic pathway involving cytotoxicWe thank Dr. Zanvil A. Cohn for continuous support and advice and for critical reading
of the manuscript, and Lauren G. Leong and Gregory Butler for excellent technical
assistance.
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granules and their contents is. itself qualitatively or quantitatively affected by
long-term culture with IL-2. If CTL and NK cells did convert to a promiscuous
mode of killing, perhaps involving a secreted mediator, it would make sense for
these cells to acquire a defense against damage by such a mechanism. In general,
it would make sense for any cytolytic cell type to acquire some form of defense
against damage that might be inflicted by its own lytic mediators.
Summary
Cloned CTLs show an unusually high resistance to lysis by effector CTLs.
Several cloned CTL lines in our laboratories are absolutely refractory to lysis by
other cloned CTLs, either (a) directly, (b) in the presence of lectin, or (c) by
PMA-induced CTLs. They can be lysed to some extent by primary CTL,
although they are <5% as sensitive as target cells normally used to assay primary
CTL lytic activity. Lysis of cloned CTLs by primary CTL effector cells is not
enhanced by the presence of lectin, and cloned T cells are also highly resistant
to lysis by primary lymphokine-activated killer cells. Cloned CTLs are highly
resistant to lysis by isolated CTL granules that contain the membranolytic pore-
forming protein (PFP or perforin), while non-CTL targets are highly susceptible
to granule-mediated killing, indicating that cloned CTLs resist lysis not only at
the intact effector cell level but also when soluble effector proteins are used.
This resistancemechanism may explain how CTLs kill but spare themselves from
being killed during the cytolytic event.
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